2024-11-13 - Analysis Report
## Thermo Fisher Scientific Inc. (TMO) Stock Analysis Report

**1. Performance vs. S&P 500**

Thermo Fisher Scientific Inc. (TMO) is a leading provider of scientific instruments, reagents, consumables, software, and services for research, healthcare, and industrial markets. 

* **Cumulative Return:** TMO: 215.84%, VOO: 179.55%
* **Performance Gap:** TMO outperformed VOO by **36.29%**. 
* **Relative Outperformance:** TMO currently sits at the **20.1 percentile** of its historical performance range against VOO. 

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 50.0% | 14.3% | 11.6% | 1.1 | 72.6 |
| 2016-2018  | 63.0% | 17.2% | 30.7% | 1.1 | 85.6 |
| 2017-2019  | 128.2% | 17.2% | 76.5% | 1.1 | 124.3 |
| 2018-2020  | 143.3% | 24.6% | 95.9% | 0.8 | 178.2 |
| 2019-2021  | 206.2% | 24.6% | 106.2% | 0.8 | 255.2 |
| 2020-2022  | 69.8% | 26.1% | 46.2% | 0.8 | 210.6 |
| 2021-2023  | 13.3% | 32.9% | -21.7% | 0.9 | 203.0 |
| 2022-2024  | -15.5% | 30.7% | -46.0% | 0.9 | 209.2 |

TMO consistently outperformed VOO over the past few years, with a notable alpha of 11.6% to 106.2%. However, recent performance (2022-2024) shows a decline, suggesting some market volatility. 

**2. Recent Price Movements**

* **Closing Price:** $540.97
* **5-day Moving Average:** $551.04
* **20-day Moving Average:** $564.46
* **60-day Moving Average:** $594.25

TMO is currently trading below all three moving averages, indicating a potential downtrend. The price is relatively close to the 5-day moving average, suggesting short-term volatility.

**3. Technical Indicators**

* **RSI:** 26.34 (Oversold territory)
* **PPO:** -0.1 (Negative momentum)
* **Delta_Previous_Relative_Divergence:** -20.55 (-) (Short-term downtrend)
* **Expected Return:** 10.76% (Long-term expected outperformance against VOO)

The technical indicators suggest an oversold and potentially bearish market sentiment. However, the positive expected return indicates potential long-term value despite the recent downtrend.

**4. Recent Earnings Performance**

| Date       | EPS | Revenue |
|------------|-----|---------|
| 2024-11-01 | 4.26 | 10.60 B$ |
| 2024-08-02 | 4.05 | 10.54 B$ |
| 2024-05-03 | 3.47 | 10.35 B$ |
| 2023-11-03 | 4.44 | 10.57 B$ |
| 2024-11-01 | 4.44 | 10.57 B$ |

TMO's recent earnings performance has shown a steady growth in revenue. However, EPS has fluctuated, showing potential for volatility. More information regarding the most recent earnings compared to expectations is needed for a comprehensive analysis.

**5. Financial Information**

**1) Revenue and Profitability:**

| Quarter      | Revenue  | Profit Margin |
|--------------|----------|---------------|
| 2024-09-30 | $10.60B  | 40.84%        |
| 2024-06-30 | $10.54B  | 41.24%        |
| 2024-03-31 | $10.35B  | 40.65%        |
| 2023-12-31 | $10.89B  | 40.35%        |
| 2023-09-30 | $10.57B  | 40.82%        |

TMO maintains consistent revenue growth with stable profit margins, indicating robust financial health. 

**2) Capital and Profitability:**

| Quarter      | Equity    | ROE       |
|--------------|-----------|------------|
| 2024-09-30 | $48.99B  | 3.33%     |
| 2024-06-30 | $47.43B  | 3.26%     |
| 2024-03-31 | $45.52B  | 2.92%     |
| 2023-12-31 | $46.73B  | 3.49%     |
| 2023-09-30 | $45.33B  | 3.78%     |

Steady equity growth and consistent ROE indicate a stable and potentially growing business with healthy capital structure. 

**6. News and Recent Issues**

To provide a comprehensive analysis, I need more specific information about the news and recent issues affecting TMO. Please specify the date range for the news analysis and provide links to relevant articles or reports.

**7. Analyst Opinions and Performance Highlights**

Provide me with specific links to articles from platforms like FINBOLD or other reputable sources to analyze recent market outlook, analyst opinions, and performance highlights.

**8. Comprehensive Analysis**

TMO exhibits strong financial performance with stable revenue growth and solid profitability. However, recent market volatility and short-term downtrend suggest cautiousness. The company's strong long-term growth potential and the current oversold position could present an opportunity for long-term investors. 

**9. Report in English**

This report provides an analysis of TMO's performance, financial health, and market sentiment. To complete the analysis, I need more information about recent news and analyst opinions. This will allow for a more comprehensive assessment of TMO's future prospects and potential investment implications. 
